Agenda Banner - CCP (3)

Online Agenda

8:45 am Login & Virtual Coffee Chat

9:00 am Chair’s Welcome

9:10 am Introducing Next Generation Capture Resins into Continuous Processing Applications

  • Ronald Maurer Principal Scientist, Downstream Process Development , Bristol-Myers Squibb

Synopsis

  • Investigated implementation of different Protein A resins into platform capture step in both batch and continuous processing
  • For continuous processing, next generation resins can offer improved productivity through decreased residence times. However, molecule-specific properties and platformed buffer selections often demand that the process be understood holistically, not just maximized for loading
  • Impurity clearance remains comparable to batch operations. Yield and cost-of-goods (resin, buffer, operator hours) become key drivers for differentiation

9:30 am Strategy for Implementation of PI in a Diverse Manufacturing Environment

Synopsis

  • Using a combination of lab scale data and process modelling to develop a business case for evaluating PI to fit in Janssen’s facilities  

9:50 am Design of Jetted Protein A Resins for Continuous Chromatography

Synopsis

  • Scalable, continuous ‘Jetting’ technology to produce beads with a narrow particle-size distribution 
  • Considerations of dynamic binding capacity (DBC), purification performance, cleaning in place and fouling of chromatography resins 
  • Proven data to demonstrate improved process economics in commercial manufacturing  

10:10 am Live Q&A – Ask Our Speakers Your Burning Questions

  • Ronald Maurer Principal Scientist, Downstream Process Development , Bristol-Myers Squibb
  • Hans Johansson Global Applications Director, Purolite Life Sciences
  • John Schreffler Principal Scientist, Janssen R&D
  • Dr. Duncan Low CEO, Claymore Biopharm LLC; Former Scientific Executive Director, Amgen

10:20 am Virtual Speed Networking

11:00 am Think Tank Fireside Chat: How to Turn Continuous Bioprocessing into Reality?

  • Dr. Duncan Low CEO, Claymore Biopharm LLC; Former Scientific Executive Director, Amgen
  • Yekaterina Lin Associate Director of Purification, AbbVie
  • Paul Randolph Principal Scientist, Janssen 
  • Hao Chen Head of Cell & Viral Drug Substance, GSK Vaccines
  • Hans Johansson Global Applications Director, Purolite Life Sciences
  • Ronald Maurer Principal Scientist, Downstream Process Development , Bristol-Myers Squibb
  • Ashley Reeder Senior Scientist - Biopharmaceutical Downstream Process Development, GSK

Synopsis

  • What needs to happen? From interest to real commitment
  • Downstream processing in biologics – challenges and opportunities
  • The choice of equipment and platform – sticking with what you know vs choosing what is right for you?
  • Adopting resin to platform or platform to resin?
  • Quality and qualification

11:50 am Closing Remarks

12:00 pm Virtual Tech Slam Tour

1:00 pm End of Inspire